Immuron (IMRN) Return on Sales (2016 - 2024)
Immuron (IMRN) posted quarterly Return on Sales of 2086148214.68% for Q4 2024, up 208614821468.0% year-over-year from N/an in Q1 2024, and up 23703124045770.84% quarter-over-quarter from 0.01% in Q4 2023.
Immuron (IMRN) Return on Sales (2016 - 2024) Analysis & Trends
Immuron's Return on Sales history runs 9 years deep, the most recent figure standing at 2086148214.68% for Q4 2024.
- In Q4 2024, Return on Sales rose 208614821468.0% year-over-year to 2086148214.68%; the TTM figure through Dec 2024 stood at 1511984978.3% (up 151198497830.0% YoY), while the FY2025 annual figure was 0.01%, up 1.0% from the prior year.
- Return on Sales for Q4 2024 stood at 2086148214.68%, up from 0.01% in the prior quarter.
- The five-year high for Return on Sales was 2086148214.68% in Q4 2024, with the low at 39089.66% in Q4 2020.
- The 5-year median for Return on Sales is 0.01% (2022), against an average of 347684854.14%.
- The sharpest annual moves came in 2020 and 2024: Return on Sales tumbled 3908965 bps in 2020, then soared 2000000000 bps in 2024.
- Immuron's Return on Sales stood at 39089.66% in 2020, then surged by 100 bps to 0.0% in 2021, then slumped by 7699892 bps to 0.01% in 2022, then slumped by 46 bps to 0.01% in 2023, then surged by 2000000000 bps to 2086148214.68% in 2024.
- Business Quant data shows IMRN's Return on Sales at 2086148214.68% in Q4 2024, 0.01% in Q4 2023, and 0.15% in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.00 Bn | 132.14 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 86.31 Bn | 78.32 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 65.24 Bn | 60.06 Bn | 1.37 Bn | 0.00% |
| 4 | Moderna | 62.41 Bn | 57.27 Bn | 52.00 Mn | -0.05% |
| 5 | BeOne Medicines | 42.25 Bn | 37.15 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 31.18 Bn | 27.88 Bn | 992.69 Mn | 0.00% |
| 7 | BioNTech SE | 28.93 Bn | 10.54 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | 0.00% |
| 9 | Royalty Pharma | 27.28 Bn | 26.44 Bn | - | 0.00% |
| 10 | Immuron | 6.78 Mn | 6.76 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 2,086,148,214.68% |
| Dec 31, 2023 | -0.01% |
| Jun 30, 2023 | -0.15% |
| Dec 31, 2022 | -0.01% |
| Dec 31, 2021 | 0.00% |
| Dec 31, 2020 | -39,089.66% |
| Dec 31, 2019 | -0.01% |
| Dec 31, 2018 | -0.02% |
| Dec 31, 2017 | -0.02% |
| Dec 31, 2016 | -0.05% |
| Jun 30, 2016 | -0.04% |